Vesugen — Khavinson bioregulator — vascular / endothelium
Vesugen (Lys-Glu-Asp) targets vascular endothelial and smooth muscle cells. Designed to restore vascular gene expression programs, improve endothelial function, and support atherosclerosis management. Reduces lipid peroxidation markers, improves microcirculation, and normalizes vascular tone in animal models. Limited human data.
نظرة عامة
هذه الصفحة جزء من مكتبة المركّبات المُصنَّفة بالأدلة في Hormonaly. جميع الادعاءات السريرية مرتبطة بمصادر علمية مُحكَّمة عبر خط أنابيب التحقق المزدوج للاستشهادات.
فئة المركّب
Khavinson bioregulator — vascular / endothelium
آلية العمل
Vesugen (Lys-Glu-Asp) targets vascular endothelial and smooth muscle cells. Designed to restore vascular gene expression programs, improve endothelial function, and support atherosclerosis management. Reduces lipid peroxidation markers, improves microcirculation, and normalizes vascular tone in animal models. Limited human data.
الوضع التنظيمي
Not FDA approved. Research peptide.
مستوى الأدلة
Very Low — animal studies + small clinical observations. Limited independent human data.